DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS
Clinical trials for DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests if personalized cholesterol targets beat standard statins for seniors with diabetes
Disease control Recruiting nowThis study is testing whether a personalized approach to lowering 'bad' cholesterol (LDL-C) works better than standard moderate-dose statins for preventing first heart attacks, strokes, or related events in people aged 70 and older with type 2 diabetes. About 2,186 participants w…
Matched conditions: DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS
Phase: NA • Sponsor: Sin Gon Kim • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
One pill to tackle diabetes and cholesterol? new trial underway
Disease control Recruiting nowThis phase 3 trial tests a new combination pill called Berlim 25/20, which contains two medicines: empagliflozin (for diabetes) and rosuvastatin (for cholesterol). The study aims to see if this single pill can better control blood sugar and LDL cholesterol in people with type 2 d…
Matched conditions: DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC